![Thérèse Croughs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thérèse Croughs
Directeur/Membre du Conseil chez
Bioxodes SA
Profil
Thérèse Croughs is a Non-Executive Director at Bioxodes SA. She was previously the Chief Medical Officer & Managing Director at Cytheris SA, a Clinical Project Leader at Bayer AG, and a Principal at Valerio Therapeutics SA from 2004 to 2013.
From 2015 to 2019, she served as the Chief Medical Officer at Neovacs SA. Dr. Croughs holds a doctorate degree from the Université Catholique de Louvain.
Postes actifs de Thérèse Croughs
| Sociétés | Poste | Début |
|---|---|---|
Bioxodes SA
 Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Directeur/Membre du Conseil | - |
Anciens postes connus de Thérèse Croughs
| Sociétés | Poste | Fin |
|---|---|---|
| NEOVACS | Directeur Technique/Scientifique/R&D | 01/06/2019 |
| BAYER AG | Corporate Officer/Principal | - |
| VALERIO THERAPEUTICS | Corporate Officer/Principal | - |
Cytheris SA
 Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Directeur Technique/Scientifique/R&D | - |
Formation de Thérèse Croughs
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Cytheris SA
Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Health Technology |
Neovacs SA
 Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioxodes SA
Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Health Technology |
